There’s Nothing New for Me in the Pipeline (Clinical Trials & Patient Participation)

No se pudo agregar al carrito

Solo puedes tener X títulos en el carrito para realizar el pago.

Add to Cart failed.

Por favor prueba de nuevo más tarde

Error al Agregar a Lista de Deseos.

Por favor prueba de nuevo más tarde

Error al eliminar de la lista de deseos.

Por favor prueba de nuevo más tarde

Error al añadir a tu biblioteca

Por favor intenta de nuevo

Error al seguir el podcast

Intenta nuevamente

Error al dejar de seguir el podcast

Intenta nuevamente

There’s Nothing New for Me in the Pipeline (Clinical Trials & Patient Participation)

Escúchala gratis

Ver detalles del espectáculo

OFERTA POR TIEMPO LIMITADO. Obtén 3 meses por US$0.99 al mes. Obtén esta oferta.

In this episode, we take a deep dive into the state of the treatment pipeline for bleeding disorders. From the way clinical trials are structured to what’s actually available for different conditions, we examine both the promise and the reality of innovation in this space. Recorded live at the NBDF Bleeding Disorders Conference, we join Mike Recht, MD, PhD, Chief Science and Medical Officer of NBDF, for a “research posters walk & talk” to explore what’s happening right now — and why so many promising treatments never make it to market.

Guests:

Mike Recht, MD, PhD

Maria Santaella, PhD(c), MSN, RN-BC, CPHON

Samantha Carlson, LMSW

Senior Advisor: Donna DiMichele, MD

Hosted by: Patrick James Lynch

Written by: Kay Vermeil

Featured Advertiser:

Sanofi

Subscribe to the Global Hemophilia Report

Show Notes:

Join Kevin as he shares about his journey with hemophilia and the hurdles he faced in communicating with friends, family, and healthcare providers about his condition. He highlights how hemophilia affects far more than just physical health — and why honest, open conversations that focus on the full patient experience, not just symptoms, are so essential.

Click here to watch his story: https://www.youtube.com/watch?v=3v1cCTbhClA&list=PLmqBxf22n4lNK82h3QZ-9YlpIjYdzDOer&index=5

Sanofi’s Global Hemophilia Survey uncovers significant care gaps and emotional challenges faced by patients and caregivers. Learn how improving health literacy and fostering better patient-provider communication are essential to addressing these inequities. Explore the findings and see how Sanofi is driving health equity for the hemophilia community. Explore the survey findings here: Global Hemophilia Survey Page.